Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

BioNTech SE ADR buy stefan

Start price
€68.00
13.07.20 / 50%
Target price
-
04.11.21
Performance (%)
29.94%
End price
€88.36
27.11.20
Summary
This prediction ended on 27.11.20 with a price of €88.36. The BUY prediction by stefan finished with a performance of 29.94%. stefan has a follow-up prediction for BioNTech SE ADR where he still thinks BioNTech SE ADR is a Buy. stefan has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
BioNTech SE ADR 7.896% 7.896% 243.124% -
iShares Core DAX® 2.149% 5.415% 21.385% 22.595%
iShares Nasdaq 100 0.838% 1.926% 44.386% 55.330%
iShares Nikkei 225® 1.143% 2.887% 27.641% 9.481%
iShares S&P 500 1.265% 3.698% 33.327% 49.646%

According to stefan what are the pros and cons of BioNTech SE ADR for the foreseeable future?

Pros
Leading role in innovation
Strong uniques
Positive Image
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Cons
Below average Marketposition
Significant cyclical dependencies
High valuation

Comments by stefan for this prediction

In the thread Biontech SE diskutieren
Prediction Buy
Perf. (%) 29.94%
Target price
Change
Ends at 04.11.21

Heute kam das Fast Track Approval der FDA für den Coronavirus Impfstoff 

In the thread Trading Biontech SE
Prediction Buy
Perf. (%) 29.94%
Target price
Change
Ends at 04.11.21

Buy closed

Current prediction by stefan for BioNTech SE ADR

buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€99.01
02.12.20
€105.00
28.11.24
-12.74%
17:24

Leading role in innovation
Strong uniques
Below average Marketposition
Significant cyclical dependencies

Stopped prediction by stefan for BioNTech SE ADR

buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€88.48
27.11.20
€120.00
13.34%
02.12.20

Leading role in innovation
Strong uniques
Below average Marketposition
Significant cyclical dependencies